1.Clinical Study of the Complications in Titanium Motility Pegged Hydroxyapatite Orbital Implant.
Jin Pyo HONG ; Jin Sook YOON ; Sang Hoon LA ; Sang Yeul LEE
Journal of the Korean Ophthalmological Society 2006;47(7):1037-1042
PURPOSE: To evaluate the complications of titanium motility pegged hydroxyapatite orbital implant. METHODS: We retrospectively reviewed the records of 77 patients who underwent drilling with titanium motility peg hydroxyapatite orbital implant from May 2000 to April 2005. RESULTS: Of 77 patients (77eyes), 22 complications in 14 eyes (18.2%) occurred: 8 cases of major discharge (10.4%), 7 cases of granulation tissue overgrowth (9.1%), 3 cases of sleeve head exposure (3.9%), 4 cases of peg extrusion (5.2%) and 2 cases of hydroxyapatite exposure around pegged hole (2.6%). CONCLUSIONS: Hydroxyapatite exposure around pegged hole was most infrequent among complications of titanium motility peg system. It is considered that the use of titanium motility pegs will increase, as a bioinert material.
Durapatite*
;
Granulation Tissue
;
Head
;
Humans
;
Orbit*
;
Orbital Implants*
;
Retrospective Studies
;
Titanium*
2.The Significance of VEGF Expression in Stage II Carcinoma of Uterine Cervix Treated with Definitive Radiotherapy.
Won PARK ; Yoon La CHOI ; Seung Jae HUH ; Sang Min YOON ; Young Je PARK ; Hee Rim NAM ; Yong Chan AHN ; Do Hoon LIM ; Hee Chul PARK
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2006;24(1):37-43
PURPOSE: We wanted to determine the clinical characteristics and prognosis according to the VEGF expression in stage II cervical carcinoma patients treated with definitive radiotherapy. MATERIALS AND METHODS: We enrolled 31 patients who were diagnosed with cervical cancer from 1995 to 2003 at Samsung Medical Center and their paraffin block tissue samples were available for study. The median age of the patients was 65 years. The mean tumor size was 4.1 cm (range: 1.2~8.2 cm). Seven patients (22.6%) were suspected of having pelvic lymph node metastasis. An external beam irradiation dose of 45-56.4 Gy was administered to the whole pelvis with a 15 MV linear accelerator, and an additional 24 Gy was given to point A by HDR intracavitary brachytherapy. VEGF staining was defined as positive when more than 10% of the tumor cells were stained. The median follow-up duration was 58 months. RESULTS: A positive VEGF expression was observed in 21 patients (67.7%). There was no significant correlation between the VEGF expression and pelvic lymph node metastasis, tumor size and the response of radiotherapy. During follow-up, 7 patients had recurrence. The complete response rate was not significant between the VEGF (-) and VEGF (+) tumors. However, the VEGF (+) tumors showed a significantly higher recurrence rate in comparison with the VEGF (-) tumors (p=0.040). The three year disease-free survival rates were 100% and 66.7%, respectively, for patients with VEGF (-) or VEGF (+) tumor (p=0.047). CONCLUSION: The VEGF expression was a significant factor for recurrence and disease-free survival. However, the significance of the VEGF expression is still controversial because of the various definitions of VEGF expression and the mismatches of the clinical data in the previous studies.
Brachytherapy
;
Cervix Uteri*
;
Disease-Free Survival
;
Female
;
Follow-Up Studies
;
Humans
;
Lymph Nodes
;
Neoplasm Metastasis
;
Paraffin
;
Particle Accelerators
;
Pelvis
;
Prognosis
;
Radiotherapy*
;
Recurrence
;
Uterine Cervical Neoplasms
;
Vascular Endothelial Growth Factor A*
3.Impact of Cytomegalovirus Disease on New-Onset Type 2 Diabetes Mellitus: Population-Based Matched Case-Control Cohort Study
Seul Gi YOO ; Kyung Do HAN ; Kyoung Hwa LEE ; Yeonju LA ; Da Eun KWON ; Sang Hoon HAN
Diabetes & Metabolism Journal 2019;43(6):815-829
BACKGROUND: A latent cytomegalovirus (CMV) cause chronic inflammation through undesirable inflation of cell-mediated immune response. CMV immunoglobulin G has been associated with cardiovascular disease and type 1 diabetes mellitus. We evaluated impact of CMV diseases on new-onset type 2 diabetes mellitus (T2DM).METHODS: From the Korean Health Insurance Review and Assessment Service claim database of entire population with 50 million, we retrieved 576 adult case group with CMV diseases diagnosed with International Statistical Classification of Diseases and Related-Health Problems 10th Revision (ICD-10) B25 code between 2010 and 2014 after exclusion of patients with T2DM to 2006. The 2,880 control patients without T2DM from 2006 to cohort entry point were selected between 2010 and 2014 by age, sex matching with case group. The subjects without new-onset T2DM were followed until 2015. T2DM, hypertension (HTN), dyslipidemia (DYS), and end-stage renal disease (ESRD) were coded as ICD-10.RESULTS: The frequency of new-onset T2DM in case group was significantly higher than that in control (5.6% vs. 2.2%, P<0.001). The group with T2DM (n=95) had higher incidence of CMV diseases than the group without T2DM (n=3,361) (33.7% vs. 16.2%, P<0.001). In multivariate regression model adjusted by age, sex, lower income, HTN, and DYS, the incidence rate (IR) of T2DM in case group was significantly higher than that in the control group (IR per 1,000, 19.0 vs. 7.3; odds ratio, 2.1; 95% confidence interval, 1.3 to 3.2). The co-existence of HTN, DYS, and ESRD with CMV diseases did not influence the IR of T2DM.CONCLUSION: CMV diseases increase the patients' risk of developing T2DM.
Adult
;
Cardiovascular Diseases
;
Case-Control Studies
;
Classification
;
Cohort Studies
;
Cytomegalovirus
;
Diabetes Mellitus, Type 1
;
Diabetes Mellitus, Type 2
;
Dyslipidemias
;
Humans
;
Hypertension
;
Immunoglobulin G
;
Incidence
;
Inflammation
;
Inflation, Economic
;
Insurance, Health
;
International Classification of Diseases
;
Kidney Failure, Chronic
;
Odds Ratio
4.Clinical Implication of Candida Score in Multidrug-Resistant Pneumonia with Airway Candida Colonization
Yeonju LA ; Da Eun KWON ; Soyoung JEON ; Sujee LEE ; Kyoung Hwa LEE ; Sang Hoon HAN ; Young Goo SONG
Infection and Chemotherapy 2022;54(2):287-297
Background:
The growth of Candida in respiratory secretions is usually considered colonization, and antifungal therapy is rarely required. The role of Candida colonization in the progression of bacterial pneumonia remains controversial. The aim of this study was to identify the clinical implication of Candida score by analyzinge the relationship with multidrug-resistant (MDR) pneumonia and prognosis in patients with airway Candida colonization.
Materials and Methods:
This study was a retrospective review of patients with airway Candida colonization by bronchial washing or bronchoalveolar lavage. The Candidascore was calculated according to the four factors (severe sepsis, surgery at baseline, total parenteral nutrition, and multifocal Candida colonization). Pneumonia related mortality or hopeless discharge expecting death was defined as a poor outcome.
Results:
A total of 148 patients were enrolled in the study. In a multivariate analysis model, Candida score was identified as an independent predictor of poor outcomes (odds ratio 2.23;95% confidential interval 1.57 – 3.17; P<0.001) in pneumonia patients with airway Candida colonization. With a Candida score of three or higher compared with low score group, it was associated with bacterial pneumonia, especially methicillin-resistant Staphylococcus aureus (MRSA) infection (0.0% vs. 15.2%, P = 0.004). In addition, patients with a high Candida score had a longer hospital stay (13 vs. 38 days, P <0.001), longer duration of intensive care (7 vs.18 days, P <0.001), and higher pneumonia-related mortality (0.0% vs. 45.5%,P <0.001) as compared to the low Candida score group. The Candida score showed a positive correlation with other pneumonia severity scales such as CURB-65 (Confusion, Urea, Respiratory rate, Blood pressure, and age ≥65 years) (r = 0.461, P <0.001), Pneumonia Severity Index (r = 0.397, P <0.001), and predisposition, insult, response, and organ dysfunction (PIRO) score (r = 0.425, P <0.001).
Conclusion
This study revealed that Candida is no longer a bystander of airway colonization, and that it affects the progression of bacterial pneumonia, including multidrug-resistant pathogens, particularly MRSA infection. Also Candida score can be used to predict the prognosis of patients with pneumonia.
5.The Clinical Significance of Simplified Scoring Criteria as a Diagnostic Tool for Overlap Syndrome in Korea.
Min Suk KIM ; Young Seok KIM ; Sang Gyune KIM ; Jin Myung BYUN ; La Young YOON ; Dong Hoon HAN ; Jong Joo MOON ; Jae Hyung NAM ; Tae Jin KIM ; Sae Hwan LEE ; Seung Won JUNG ; Hong Soo KIM ; Boo Sung KIM ; Hee Kyung KIM
Korean Journal of Medicine 2013;84(2):211-220
BACKGROUND/AIMS: The diagnosis of primary billiary cirrhosis (PBC)-autoimmune hepatitis (AIH) overlap syndrome remains challenging. In 2008, a simplified scoring system was proposed by the International Autoimmune Hepatitis Group, which aimed for wider applicability in routine clinical practice. We evaluated the performance of the new simplified AIH scoring criteria as a diagnostic tool for overlap syndrome. METHODS: We retrospectively reviewed the clinical histories, chemistry, autoimmune studies, and liver biopsy results of 25 patients diagnosed with PBC who visited Soonchunhyang University Hospital, Bucheon and Seoul, between November 2004 and December 2009. Parameters relevant to the revised and simplified scoring criteria were recorded, and outcomes were compared between those with and without features of overlap syndrome. RESULTS: Of 25 patients with a definite diagnosis of PBC, five (20%) were diagnosed with overlap syndrome using the revised criteria, and 18 patients (72%) were diagnosed with the simplified criteria. Those patients diagnosed according to the simplified scoring criteria revealed an increased frequency of anti-nuclear antibody (p = 0.030) and serum IgG levels (p = 0.092). Additionally, advanced fibrosis was significantly more frequent in patients with overlap syndrome (p = 0.017). CONCLUSIONS: The simplified scoring criteria seemed to be useful as a diagnostic tool to recognize overlap syndrome in Korea. However, a relatively small number of patients were included in our study, so further clinical trials based on larger populations should be performed.
Biopsy
;
Fibrosis
;
Hepatitis
;
Hepatitis, Autoimmune
;
Humans
;
Immunoglobulin G
;
Korea
;
Liver
;
Liver Cirrhosis
;
Retrospective Studies
6.The Antiapoptotic Effect of Vascular Endothelial Growth Factor and Angiopoietin-1 on Glomerular Endothelial Cells in Adriamycin or Cisplatin-induced Apoptosis.
Won KIM ; Cheol Su LIM ; Mi Jung SUNG ; Sung Hoon KIM ; Sang Ok MOON ; Sik LEE ; Bang Joo LA ; Sung Kwang PARK ; Sung Kyew KANG ; Hyung Jin KIM ; Gou Young KOH
Korean Journal of Nephrology 2002;21(4):569-583
BACKGROUND: Because glomerular endothelium play a pivotal role in the renal diseases, damage of glomerular endothelial cells lead to progression of glomerular sclerosis and decrement of renal function. Apoptotic damage of cells is an important mechanism in renal disease. Therefore, several growth factors that have antiapoptotic effect may have a protective role in maintaining a renal function in apoptotic cell injury. METHODS: The present study evaluated whether cisplatin or adriamycin induce apoptosis in glomerular endothelial cells. We also evaluated the antiapoptotic effect of angiopoietin-1 and VEGF in cisplatin or adriamycin- induced apoptosis. RESULTS: Cisplatin or adriamycin induced apoptosis in glomerualr endothelial cell in dose dependent manner. Angiopoietin-1 and VEGF produced antiapoptotic effect in cisplatin or adriamycin-induced apoptosis in a dose dependent manner. The antiapoptotic effect of angiopoietin-1 was more potent than that of VEGF in glomerualr endothelial cells. Wortmannin, a phosphatidylinositol 3'-kinase inhibitor decrease the angiopoietin-1 or VEGF-induced antiapoptotic effect. CONCLUSION: These results suggest that angiopoietin-1 and VEGF may be a strong survival factor for the glomerular endothelial cells in the cisplatin or adriamycin-induced apoptosis through phosphatidylinositol 3'-kinase/Akt. Therefore, pretreatment of angiopoietin-1 and VEGF could play a beneficial role for maintaining normal glomerular endothelial cell integrity before and during systemic cisplatin or adriamycin therapy.
Angiopoietin-1*
;
Apoptosis*
;
Cisplatin
;
Doxorubicin*
;
Endothelial Cells*
;
Endothelium
;
Intercellular Signaling Peptides and Proteins
;
Phosphatidylinositols
;
Sclerosis
;
Vascular Endothelial Growth Factor A*
7.Extranodal Follicular Dendritic Cell Sarcoma with Rapid Growth in Parapharynx: A Case Report.
Jung Soo PYO ; Guhyun KANG ; Sung Im DO ; Seoung Wan CHAE ; Kyungeun KIM ; Sang Hyuk LEE ; Yoon La CHOI ; Joon Hyuk CHOI ; Jin Hee SOHN ; Dong Hoon KIM
Korean Journal of Pathology 2012;46(3):306-310
Follicular dendritic cell sarcoma (FDCS) is a rare malignancy arising from the antigen-presenting cells in the lymph node and extranodal tissue. We describe a 31-year-old male patient who presented with a swelling of the left parapharynx. The radiologic findings showed a 4.7x4.5x1.9 cm-sized, ill-defined mass in the left parapharyngeal space. A fine-needle aspiration cytology was performed and it showed scattered, irregular, cohesive clusters of tumor cells with a spindle-to-ovoid shape with irregular contours in a background of lymphocytes. Based on these findings, a diagnosis of spindle cell neoplasm was made. The surgically resected tumor was composed of elongated, ovoid or polygonal cells showing positive immunohistochemistry for CD21, CD23, and CD35. Postoperatively, the residual tumor was observed to undergo a rapidly growth. There is an overlap in the cytologic and histologic findings between FDCS of the parapharynx and other tumors. Pathologists should therefore be aware of its characteristics not only to provide an accurate diagnosis but also to recommend the appropriate clinical management.
Male
;
Humans
8.Extranodal Follicular Dendritic Cell Sarcoma with Rapid Growth in Parapharynx: A Case Report.
Jung Soo PYO ; Guhyun KANG ; Sung Im DO ; Seoung Wan CHAE ; Kyungeun KIM ; Sang Hyuk LEE ; Yoon La CHOI ; Joon Hyuk CHOI ; Jin Hee SOHN ; Dong Hoon KIM
Korean Journal of Pathology 2012;46(3):306-310
Follicular dendritic cell sarcoma (FDCS) is a rare malignancy arising from the antigen-presenting cells in the lymph node and extranodal tissue. We describe a 31-year-old male patient who presented with a swelling of the left parapharynx. The radiologic findings showed a 4.7x4.5x1.9 cm-sized, ill-defined mass in the left parapharyngeal space. A fine-needle aspiration cytology was performed and it showed scattered, irregular, cohesive clusters of tumor cells with a spindle-to-ovoid shape with irregular contours in a background of lymphocytes. Based on these findings, a diagnosis of spindle cell neoplasm was made. The surgically resected tumor was composed of elongated, ovoid or polygonal cells showing positive immunohistochemistry for CD21, CD23, and CD35. Postoperatively, the residual tumor was observed to undergo a rapidly growth. There is an overlap in the cytologic and histologic findings between FDCS of the parapharynx and other tumors. Pathologists should therefore be aware of its characteristics not only to provide an accurate diagnosis but also to recommend the appropriate clinical management.
Male
;
Humans
9.EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Song Ee PARK ; Jae Myoung NOH ; You Jin KIM ; Han Sang LEE ; Jang Ho CHO ; Sung Won LIM ; Yong Chan AHN ; Hongryull PYO ; Yoon La CHOI ; Joungho HAN ; Jong Mu SUN ; Se Hoon LEE ; Jin Seok AHN ; Keunchil PARK ; Myung Ju AHN
Cancer Research and Treatment 2019;51(2):493-501
PURPOSE: This study was conducted to evaluate the relationship between epidermal growth factor receptor (EGFR) mutation and clinical outcomes in patients with stage III non-squamous cell lung cancer treated with definitive concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: From January 2008 to December 2013, the medical records of 197 patients with stage III non- squamous non-small cell lung cancer treated with definitive CCRT were analyzed to determine progression-free survival (PFS) and overall survival (OS) according to EGFR mutation status. RESULTS: Among 197 eligible patients, 81 patients were EGFR wild type, 36 patients had an EGFR mutation (exon 19 Del, n=18; L858R, n=9, uncommon [G719X, L868, T790M], n=9), and 80 patients had unknown EGFR status. The median age was 59 years (range, 28 to 80 years) and 136 patients (69.0%) were male. The median follow-up duration was 66.5 months (range, 1.9 to 114.5 months). One hundred sixty-four patients (83.2%) experienced disease progression. Median PFS was 8.9 months for the EGFR mutation group, 11.8 months for EGFR wild type, and 10.5 months for the unknown EGFR group (p=0.013 and p=0.042, respectively). The most common site of metastasis in the EGFR mutant group was the brain. However, there was no significant difference in OS among the three groups (34.6 months for EGFR mutant group vs. 31.9 months for EGFR wild type vs. 22.6 months for EGFR unknown group; p=0.792 and p=0.284). A total of 29 patients (80.6%) with EGFR mutation were treated with EGFR tyrosine kinase inhibitor (gefitinib, n=24; erlotinib, n=3; afatinib, n=2) upon progression. CONCLUSION: EGFR mutation is associatedwith short PFS and the brain is the most common site of distant metastasis in patients with stage III non- squamous cell lung cancer treated with CCRT.
Brain
;
Carcinoma, Non-Small-Cell Lung
;
Chemoradiotherapy
;
Disease Progression
;
Disease-Free Survival
;
Epithelial Cells
;
Erlotinib Hydrochloride
;
Follow-Up Studies
;
Humans
;
Lung Neoplasms
;
Lung
;
Male
;
Medical Records
;
Neoplasm Metastasis
;
Protein-Tyrosine Kinases
;
Receptor, Epidermal Growth Factor
10.Clinical Characteristics and Treatment Outcomes of Pulmonary Diseases Caused by Coinfections With Multiple Nontuberculous Mycobacterial Species
Sol KIM ; A La WOO ; Seung Hyun YONG ; Ah Young LEEM ; Su Hwan LEE ; Sang Hoon LEE ; Song Yee KIM ; Kyungsoo CHUNG ; Eun Young KIM ; Ji Ye JUNG ; Young Ae KANG ; Moo Suk PARK ; Young Sam KIM ; Youngmok PARK
Journal of Korean Medical Science 2024;39(20):e167-
Background:
Coinfections with multiple nontuberculous mycobacterial (NTM) species have not been widely studied. We aimed to evaluate the clinical characteristics and treatment outcomes in patients with NTM-pulmonary disease (PD) caused by coinfection with multiple NTM species.
Methods:
We retrospectively reviewed patients with NTM-PD at a tertiary referral hospital in Korea between March 2012 and December 2018. Coinfection was defined as two or more species of NTM pathogens isolated from the same respiratory specimen or different specimens within three months.
Results:
Among 1,009 patients with NTM-PD, 147 (14.6%) NTM coinfections were observed (average age 64.7 years, 69.4% women). NTM species were identified more frequently (median 6 vs. 3 times, P < 0.001) in the coinfection group than in the single species group, and follow-up duration was also longer in the coinfection group (median 44.9 vs. 27.1 months, P < 0.001). Mycobacterium avium complex (MAC) and M. abscessus and M. massiliense (MAB) were the dominant combinations (n = 71, 48.3%). For patients treated for over six months in the MAC plus MAB group (n = 31), sputum culture conversion and microbiological cure were achieved in 67.7% and 41.9% of patients, respectively. We divided the MAC plus MAB coinfection group into three subgroups according to the target mycobacteria; however, no statistical differences were found in the treatment outcomes.
Conclusion
In NTM-PD cases, a significant number of multiple NTM species coinfections occurred. Proper identification of all cultured NTM species through follow-up is necessary to detect multispecies coinfections. Further research is needed to understand the nature of NTM-PD in such cases.